The All New Synthetic | GenomeWeb

The All New Synthetic


Randy Rettberg is building an industry -- or at least he's trying. While interest in synthetic biology continues to grow by leaps and bounds, its use in real-world science has remained fairly minimal. Synthetic biology, or the goal of developing an engineering discipline that can build biological systems in the way that other engineers can build chemical or computational systems, is still young. "I think that the field is very, very early," says Rettberg at MIT. While it's 2007 for the rest of us, "in many ways it's much more like 1850 in this corner of the world.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.